Discrepancy between Mycobacterium tuberculosis -Specific Gamma Interferon Release Assays Using Short and Prolonged In Vitro Incubation
- 1 July 2007
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 14 (7) , 880-885
- https://doi.org/10.1128/cvi.00132-07
Abstract
The sensitivities of various gamma interferon release assays (IGRAs) for the detection of past latent Mycobacterium tuberculosis infection are not known. In this study, we aimed to assess the effects of various IGRA formats and in vitro incubation periods on test outcome. The results of the tuberculin skin test (TST) were compared with those of the QuantiFERON-TB Gold in-tube (QFT-GIT) test, an overnight enzyme-linked immunospot assay (ELISPOT), and a 6-day lymphocyte stimulation test (LST) by using the same M. tuberculosis -specific peptides and samples from 27 TST-positive persons with a history of exposure to M. tuberculosis , 4 patients cured of tuberculosis (TB), and 9 TST-negative controls. Among the TST-positive persons, the LST was more frequently positive (92%; P < 0.01) than either the QFT-GIT test (33%) or ELISPOT (46%). While good agreement was observed between the QFT-GIT test and ELISPOT (κ = 0.71) and between TST and LST (κ = 0.78), the agreement between TST or LST, on the one hand, and the QFT-GIT test or ELISPOT, on the other, was poor. These data indicate that the QFT-GIT test and overnight ELISPOT are less sensitive for the detection of past latent TB than the 6-day LST. The observed discrepancies between these IGRAs are most likely related to differences in incubation periods. Whether TST-positive persons with positive LST results but negative QFT-GIT and ELISPOT results are at risk for the development of TB needs to be elucidated before short-incubation IGRAs can be used for the screening of individuals for latent TB before immunosuppressive treatment.Keywords
This publication has 32 references indexed in Scilit:
- Posttransplant Mycobacterium Tuberculosis Disease Following Liver Transplantation and the Need for Cautious Evaluation of Quantiferon TB GOLD Results in the Transplant Setting: A Case ReportTransplantation Proceedings, 2006
- Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective studyThe Lancet, 2006
- Enzyme-linked Immunospot and Tuberculin Skin Testing to Detect Latent Tuberculosis InfectionAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Mycobacterium tuberculosis Infection in Health Care Workers in Rural IndiaJAMA, 2005
- Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic reviewThe Lancet Infectious Diseases, 2004
- Comparison of Tuberculin Skin Test and New Specific Blood Test in Tuberculosis ContactsAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Gamma Interferon-Based Immunodiagnosis of Tuberculosis: Comparison between Whole-Blood and Enzyme-Linked Immunospot MethodsJournal of Clinical Microbiology, 2004
- Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreakThe Lancet, 2003
- Tuberculin Skin Testing and In Vitro T Cell Responses to ESAT‐6 and Culture Filtrate Protein 10 after Infection withMycobacterium marinumorM. kansasiiThe Journal of Infectious Diseases, 2002
- Evolution of Epitope-Specific Memory CD4+ T Cells After Clearance of Hepatitis C VirusThe Journal of Immunology, 2002